Source comparison
Side-by-Side Comparison: Ipamorelin/Sermorelin vs. Ipamorelin/CJC-1295
GHRH Component Half-Life ~10-20 min (Sermorelin) ~30-60 min (CJC-1295 No DAC) GH Pulse Profile Sharp, discrete pulses — closer to endogenous pattern Broader, sustained GH elevation per dose GHRH Receptor Resensitization Faster — short Sermorelin half-life allo
This comparison does not assign a generated winner or score.
- GHRH Component Half-Life
- ~10-20 min (Sermorelin)
- ~30-60 min (CJC-1295 No DAC)
- GH Pulse Profile
- Sharp, discrete pulses — closer to endogenous pattern
- Broader, sustained GH elevation per dose
- GHRH Receptor Resensitization
- Faster — short Sermorelin half-life allows receptor recovery
- Slower — longer CJC-1295 occupancy delays resensitization
- Best Research Application
- Studies requiring physiologic pulsatile GH pattern; receptor dynamics research
- Studies requiring sustained GH elevation; dose-interval flexibility
- Administration Frequency
- Multiple times daily often needed for sustained effect
- 1-2x daily typically sufficient for sustained GH support
- IGF-1 Elevation Sustained?
- Yes with frequent dosing; less so with single-dose protocols
- More consistent IGF-1 elevation with standard dosing
- Receptor Desensitization Risk
- Lower — pulsatile pattern preserves receptor sensitivity
- Moderate with high-frequency dosing
- Research Precedent
- Extensive for each compound individually; combination data emerging
- Well-established combination research base